Helium / oxygen mixed gas inhalation therapy ( DrugBank: Oxygen, Helium )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 330 | 先天性気管狭窄症／先天性声門下狭窄症 | 1 |
330. 先天性気管狭窄症／先天性声門下狭窄症
臨床試験数 : 1 / 薬物数 : 3 - (DrugBank : 2) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-JMA-IIA00357 | 01/07/2018 | 19/06/2018 | Phase II trial of helium / oxygen mixed gas for respiratory failure secondary to airway obstructive lesion in children | Phase II trial of helium / oxygen mixed gas for respiratory failure secondary to airway obstructive lesion in children | Respiratory failure due to airway obstructive lesion such as acute bronchiolitis, congenital tracheal stenosis, bronchial asthma attack | Intervention type:DRUG. Intervention1:Helium / oxygen mixed gas inhalation therapy, Dose form:INSUFFLATION, Route of administration:INHALATIONAL, intended dose regimen:Helium / oxygen mixed gas . | Tokyo Metropolitan Children's Medical Center | National Center for Child Health and Development | Recruiting | No Limit | <20 YEARS | BOTH | 15 | Phase 2 | Japan |